D-0626-2026 Class II Ongoing
FDA drug recall D-0626-2026 was initiated by Annora Pharma Private Limited on Jun 4, 2026 and is designated Class II. Reason for recall: Presence of a Foreign Tablets: Complaint received, possible mix-up of Selexipag 1000 mcg tablet in a bottle of Lacosamide Tablets USP, 100mg. The recall status is ongoing. Affected quantity: 31,392 60-count bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 1, 2026
- Initiation Date
- Jun 4, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 31,392 60-count bottles
Product description
Lacosamide Tablets, USP, C V, 100mg, Rx only, 60-count bottle, By: Annora Pharma Pvt., Ltd, Sangareddy -502313, Telangana, India, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, NDC 31722-813-60.
Reason for recall
Presence of a Foreign Tablets: Complaint received, possible mix-up of Selexipag 1000 mcg tablet in a bottle of Lacosamide Tablets USP, 100mg.
Distribution pattern
Nationwide in the USA
Code information
Lot: A253999, A254000, Expires: 09/30/2027.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0626-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026